Major The administration of colistimethate sodium may increase the risk of developing nephrotoxicity, even in patients who have normal renal function. Alternative drug delivery for patients undergoing cataract surgery as demonstrated in a canine model. Hepatic Effect and Table 2. In addition, normotensive patients receiving antihypertensive therapy had higher increases in blood pressure than subjects with uncontrolled hypertension or normotensive subjects receiving no hypertensive therapy.
|Date Added:||2 November 2006|
|File Size:||30.91 Mb|
|Operating Systems:||Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X|
|Price:||Free* [*Free Regsitration Required]|
Ketorolac dosing, indications, interactions, adverse effects, and more
Major Myelosuppression, primarily neutropenia and thrombocytopenia, is the dose-limiting toxicity of temozolomide. Naprapac copackaged with lansoprazole is a registered trademark of Syntex Pharmaceuticals International Ltd. Minor Concurrent use of nephrotoxic agents, such rpescribing NSAIDs, with ganciclovir should be done cautiously to avoid additive nephrotoxicity.
Moderate The manufacturer recommends using aprotinin cautiously in patients that are receiving drugs that can affect renal function, such as NSAIDs, as the risk of renal impairment may be increased. The concomitant use of other potassium-sparing antihypertensives with NSAIDs has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.
Since cross reactivity, including bronchospasm, between aspirin and other nonsteroidal anti-inflammatory drugs has been reported in such aspirin-sensitive patients, TORADOL ketorolac tromethamine should prescrribing be administered to patients with this form of aspirin sensitivity and should be used with caution in patients with preexisting asthma. This effect is most significant in patients receiving concurrent antihypertensive agents and long-term NSAID therapy.
Inject slowly and deeply into muscle IV: If clinical signs and symptoms consistent with liver disease develop, or if systemic manifestations occur eg, eosinophiliarash, etc.
Prescribing Information – OMIDRIA
Chronic alcoholism is often associated with hypoprothrombinemia ktorolac this condition increases the risk of bleeding. Fluid retention, edema, retention of NaCl, oliguriaelevations of serum urea nitrogen and creatinine have been reported in clinical trials with TORADOL ketorolac tromethamine.
Adults weighing 50 kg or more.
The unit is designed for a single day of use. As compared to prescribint younger than 65 years of age, the mean elimination half-life in the elderly was prolonged 7 hours after an IM dose. Food and Drug Administration. Doravirine; Lamivudine; Tenofovir disoproxil fumarate: Patients should be monitored closely for bleeding.
A similar interaction may occur with fosphenytoin. Moderate Concomitant use of medicines with potential to alter renal perfusion or function such as nonsteroidal anti-inflammatory drugs NSAIDs may increase the risk of acute phosphate nephropathy in patients taking sodium phosphate monobasic monohydrate; sodium phosphate dibasic anhydrous.
COX-1 is responsible for prostaglandin synthesis in response to stimulation by circulating hormones, as well as maintenance of normal renal function, gastric mucosal integrity, and hemostasis. NSAIDs cause prescribiing dose-dependent reduction in prostaglandin formation, which may result in a reduction in renal blood flow leading to renal insufficiency and an increase in blood pressure that are often accompanied by peripheral edema and weight gain.
Prostaglandin inhibitors may impair fertility and are not recommended for use in women attempting to conceive.
Ketoroac Monitor patients for signs or symptoms of bleeding during concurrent use of warfarin and nonsteroidal antiinflammatory drugs NSAIDs. Also, doses higher than recommended will not increase efficacy but will increase the risk of developing serious adverse events; the maximum recommended daily oral dose is significantly lower than the maximum daily parenteral dose. Patients and physicians should remain alert for signs and symptoms of GI ulceration and bleeding during NSAID therapy and promptly initiate additional evaluation and treatment if a serious GI adverse event is suspected.
Severe Increased adverse gastrointestinal and other effects are possible if ketorolac is used with salicylates. Patients receiving ketorolac concurrently with antineoplastic agents, antithymocyte globulin, or strontium chloride should be monitored closely for bleeding. Administration IV Incompatibilities Additive: Diuretics Clinical studies, as well as postmarketing observations, have shown that TORADOL ketorolac tromethamine can reduce the natriuretic effect of furosemide and thiazides in some informafion.
The use of TORADOL ketorolac tromethamine is contraindicated in nursing mothers because of the potential adverse effects of prostaglandin-inhibiting drugs on neonates.
The white film-coating contains prescrining methylcellulose, polyethylene glycol and titanium dioxide.
Dipyridamole can block membrane transport of cytarabine in tumor cells, therefore decreasing its antineoplastic activity. Minor Drospirenone has antimineralocorticoid effects; the progestin may increase serum potassium. Major The administration of colistimethate sodium may increase the risk of developing nephrotoxicity, even in patients who have normal renal function.
Step Therapy Drugs that have step therapy associated informaion each prescription. Forced diuresisalkalization of urine, hemodialysis or hemoperfusion may not be useful due to high protein binding.
Demonstrated hypersensitivity to ketorolac or allergic manifestations to aspirin or other NSAIDs; appropriate counteractive measures must be available when first ketorolac injection is given.